Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34451
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnkravs, Melissa J-
dc.contributor.authorUdy, Andrew A-
dc.contributor.authorByrne, Kathleen-
dc.contributor.authorKnowles, Serena-
dc.contributor.authorHammond, Naomi-
dc.contributor.authorSaxena, Manoj K-
dc.contributor.authorReade, Michael C-
dc.contributor.authorBailey, Michael-
dc.contributor.authorBellomo, Rinaldo-
dc.contributor.authorDeane, Adam M-
dc.date2023-
dc.date.accessioned2023-12-13T05:25:37Z-
dc.date.available2023-12-13T05:25:37Z-
dc.date.issued2020-12-
dc.identifier.citationCritical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine 2020-12; 22(4)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34451-
dc.description.abstractObjective: To characterise the assessment and management of delirium in patients admitted to intensive care units (ICUs) in Australia and New Zealand. Methods: We conducted a multicentre observational point prevalence study across 44 adult Australian and New Zealand ICUs. Data were extracted for all patients in the ICU in terms of assessment and treatment of delirium. ICU-level data were collected regarding the use of explicit protocols related to delirium. Results: We studied 627 patients, with 54% (336/627) having at least one delirium screening assessment performed. The Confusion Assessment Method for the ICU (CAM-ICU) was the most frequently used tool (88%, 296/336). Of patients assessed, 20% (68) were identified to have delirium. Eighteen per cent (111) of patients were administered a drug to manage delirium, with 41% (46) of those receiving a drug having no recorded assessment for delirium on that day. Of the drugs used to treat delirium, quetiapine was the most frequently administered. Physical restraints were applied to 8% (48/626) of patients, but only 17% (8/48) of such patients had been diagnosed with delirium. Most physically restrained patients either did not have delirium diagnosed (31%, 15/48) or had no formal assessment recorded (52%, 25/48) on that day. Conclusions: On the study day, more than 50% of patients had a delirium screening assessment performed, with 20% of screened patients deemed to have delirium. Drugs that are prescribed to treat delirium and physical restraints were frequently used in the absence of delirium or the formal assessment for its presence.en_US
dc.language.isoeng-
dc.titleA multicentre point prevalence study of delirium assessment and management in patients admitted to Australian and New Zealand intensive care units.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCritical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicineen_US
dc.identifier.affiliationThe University of Melbourne, Melbourne Medical School, Department of Medicine and Radiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Intensive Care Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Pharmacy Department, Royal Melbourne Hospital, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationIntensive Care Unit, The Alfred Hospital, Melbourne, VIC, Australia.;Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationIntensive Care Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationCritical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.;Malcolm Fisher Department of Intensive Care Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationCritical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.;Intensive Care Unit, Bankstown Hospital, Sydney, NSW, Australia.en_US
dc.identifier.affiliationRoyal Brisbane and Women's Hospital Clinical School, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.;Joint Health Command, Australian Defence Force, Canberra, ACT, Australia.en_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationIntensive Careen_US
dc.identifier.affiliationThe University of Melbourne, Melbourne Medical School, Department of Medicine and Radiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.;Intensive Care Unit, Royal Melbourne Hospital, Melbourne, VIC, Australia.en_US
dc.identifier.doi10.51893/2020.4.OA8en_US
dc.type.contentTexten_US
dc.identifier.pubmedid38046881-
dc.description.volume22-
dc.description.issue4-
dc.description.startpage355-
dc.description.endpage360-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

20
checked on Jan 12, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.